Jason Go, MD
Cardiovascular Disease · Fargo, NDNPI 1447475637
Payments from drug & device makers
What this record shows
8 manufacturers reported payments, led by Medtronic at 38.0% of the total. Reporting peaked in 2023 at $5,658 and has fallen 76.1% since, to $1,350 in 2024.
Across 285 payments — averaging $51.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$6K
- Edwards Lifesciences$5K
- Boston Scientific$2K
- Shockwave Medical, Inc$1K
- Abbott$187
- Heartflow, Inc.$144
- plus $111 from 2 others
Across 44 payments — averaging $13,028 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$457K
- AstraZeneca$94K
- Biotronik Inc.$16K
- Astrazeneca UK Limited$5K
- Medtronic$2K
What the payments were for
- Travel & lodging$7,99055%
- Food & beverage$6,61045%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 36 | $5,543 |
| Edwards Lifesciences | 46 | $5,434 |
| Boston Scientific | 110 | $1,762 |
| Shockwave Medical, Inc | 80 | $1,419 |
| Abbott | 7 | $187 |
| Heartflow, Inc. | 1 | $144 |
| Abiomed | 4 | $85 |
| Siemens Medical Solutions USA, Inc. | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,600 in reported general payments places this provider in the 75th percentile of 35 cardiovascular disease providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Repatha SureclickEvolocumab | 50 | $57,969 |
| EliquisApixaban | 57 | $44,714 |
| Praluent PenAlirocumab | 25 | $23,834 |
| EntrestoSacubitril/Valsartan | 18 | $16,629 |
| JardianceEmpagliflozin | 17 | $10,870 |
| BrilintaTicagrelor | 14 | $6,462 |
| ClopidogrelClopidogrel Bisulfate | 392 | $2,893 |
| Ranolazine ErRanolazine | 33 | $1,861 |
| Metoprolol Succinate | 97 | $1,469 |
| Atorvastatin Calcium | 139 | $1,235 |
| Rosuvastatin Calcium | 71 | $761 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 67 | $654 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 42 | $548 |
| Amiodarone Hcl | 18 | $374 |
| Metoprolol Tartrate | 28 | $348 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Fargo
- Thomas HaldisFargo$37K
- Matthew GlogozaFargo$36K
- Padmaraj DuvvuriFargo$7K
- Brian GrondahlFargo$6K
- Ahmed AbuzaanonaFargo$4K
- Aaron SmithFargo$2K
- Ralph MoralesFargo$1K
- David ClardyFargo$967
- Abdallah MansourFargo$614
- Oluwaseun FashanuFargo$445
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.